Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:30 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 529–552 of 13,915 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Obstructive Hypertrophic Cardiomyopathy (oHCM)
Interventions: Aficamten (5 mg, 10 mg, 15 mg, and 20 mg), Placebo to match aficamten; Drug
Lead sponsor: Cytokinetics; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 48
States / cities: Anchorage, Alaska • La Jolla, California • Los Angeles, California + 39 more

Conditions: Breast Neoplasms, Neoplasm Metastasis
Interventions: Growing Resiliency And CouragE with Cancer™ (GRACE); Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cardiovascular Diseases, Depression
Interventions: Online Mindfulness Based Cognitive Therapy, Online Cognitive Behavioral Therapy, Fitbit Alone; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 506 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Migraine
Interventions: Xeomin, Placebo; Drug
Lead sponsor: Merz Therapeutics GmbH; Industry
Eligibility: 18 Years and older
Enrollment: 808 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 48
States / cities: Chandler, Arizona • Phoenix, Arizona • Little Rock, Arkansas + 42 more

Conditions: Colon Polyps
Interventions: Educational Training; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Hair Thinning
Interventions: Active Comparator- Xtressé™ Supplement and Serum, Placebo Comparator- Placebo Supplement and Serum; Dietary Supplement
Lead sponsor: The Center for Clinical and Cosmetic Research; Other
Eligibility: 28 Years to 65 Years · Female only
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Birmingham, Alabama • Aventura, Florida

Conditions: COPD
Interventions: Formoterol Fumarate, Tiotropium Bromide; Drug
Lead sponsor: Dey; Industry
Eligibility: 40 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 17
States / cities: Phoenix, Arizona • Los Angeles, California • Sepulveda, California + 14 more

Conditions: Physical Activity
Interventions: Activity monitor, Activity device; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years to 45 Years
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetes Mellitus
Interventions: Pharmacist Management, Usual care; Other
Lead sponsor: Advantage Health Physician Network; Other
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Crime, Juvenile Delinquency
Interventions: Big Brothers Big Sisters Community-Based Mentoring Program; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 10 Years and older
Enrollment: 1,361 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Postpartum
Interventions: Offer of Participant's Choice of Contraception Method; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 15 Years to 35 Years · Female only
Enrollment: 208 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Gastroesophageal Reflux
Interventions: Nissen fundoplication; Procedure
Lead sponsor: Johns Hopkins University; Other
Eligibility: Up to 24 Months
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Sphincter Ani Incontinence, Obstetric Trauma
Interventions: Physical Therapy (PT) and Behavioral Therapy (BT); Behavioral
Lead sponsor: TriHealth Inc.; Other
Eligibility: 18 Years and older · Female only
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Delirium
Interventions: Control, Preventative Delirium Protocol; Other
Lead sponsor: Rush University Medical Center; Other
Eligibility: 65 Years to 89 Years
Enrollment: 263 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Aggression, Anger, Posttraumatic Stress Disorder
Interventions: Cognitive Behavioral Therapy, Present Centered Therapy; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Interventions: OC-L/Montanide ISA 51 VG, Ampligen, Prevnar; Biological
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Kidney Disease (Stage 3-4), Vascular Function, Cognitive Functions, Cerebrovascular Function, Blood Pressure
Interventions: Equol, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 50 Years and older · Female only
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Diabetes, Type I
Interventions: Technosphere Insulin, Active comparator; Drug
Lead sponsor: Mannkind Corporation; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 589 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 61
States / cities: Mobile, Alabama • Chandler, Arizona • Chula Vista, California + 48 more

Conditions: Hypertension, Prehypertension
Interventions: MB-BP, Enhanced Usual Care Control; Behavioral · Other
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Autistic Disorder, Asperger Syndrome, Autism Spectrum Disorder
Interventions: aripiprazole; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 30 Months to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Gonorrhea, Neisseria Gonorrhoeae, Chlamydia Trachomatis
Interventions: Patient delivered partner therapy, Targeted public health partner services; Other · Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 14 Years and older
Enrollment: 33,222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 2
States / cities: Olympia, Washington • Seattle, Washington

Conditions: Actinic Keratoses
Interventions: ALA (5-aminolevulinic acid), Blue light therapy; Drug · Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Digestive Discomfort
Interventions: Dietary Supplement: conventional cow's milk consumption, and then A1PF milk consumption, Dietary Supplement: A1PF milk consumption, and then conventional cow's milk consumption; Other
Lead sponsor: a2 Milk Company Ltd.; Industry
Eligibility: 18 Years to 68 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Control Group, Mexico-based NSS FOPL, Brazil-based NSS FOPL
Interventions: Experimental : Mexico-based NSS FOPL, Experimental : Brazil-based NSS FOPL; Other
Lead sponsor: George Washington University; Other
Eligibility: 20 Years and older
Enrollment: 1,068 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Search by objective public record fields.

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

A Trial to Strengthen Existential Resiliency Among Women With Metastatic Breast Cancer

Healthy Hearts Healthy Minds

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

A Prospective Trial of an Endoscopic Quality Improvement Project

Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair

A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD

Be Fit in Residency: a Randomized Controlled Trial of an Activity Device Among Medicine Residents

Pharmacists Management of Diabetes

Randomized Controlled Trial of Big Brothers Big Sisters Mentoring for Prevention of Crime and Delinquency

Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women

Clinical Trial Comparing Open and Laparoscopic Nissen Fundoplication in Children

Physical Therapy for Women With Obstetric Trauma and Anal Incontinence

Preventative Delirium Protocol in Elderly Patients

Group CBT for Aggression in Veterans

A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Equol and Vascular Function in Women With Chronic Kidney Disease

Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes

UH3 Phase - Mindfulness-Based Blood Pressure Reduction (MB-BP) : Stage 2a RCT

Study of Aripiprazole to Treat Children and Adolescents With Autism

Washington State Community Expedited Partner Treatment (EPT) Trial

Photodynamic Therapy Incubation Times for Actinic Keratosis

A1 Beta-casein-free Milk in Milk-intolerant Participants

NSS Grocery Store Brazil